Key result
This educational article presents a clinical scenario to introduce a guide on evaluating the medical literature regarding the use of warfarin for stroke prevention in nonvalvular atrial fibrillation.
Why the study?
Do long-term anticoagulants (warfarin) reduce the risk of embolic stroke without excessive risk of hemorrhage in patients with nonvalvular atrial fibrillation?
Population
65-year-old man with controlled hypertension and a 6-month history of atrial fibrillation resistant to…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Offers clinicians a framework to appraise warfarin evidence in AF; leaves open integration with contemporary therapies.
Structured PICO
Do long-term anticoagulants (warfarin) reduce the risk of embolic stroke without excessive risk of hemorrhage in patients with nonvalvular atrial fibrillation?
P
Population
65-year-old man with controlled hypertension and a 6-month history of atrial fibrillation resistant to cardioversion, without valvular or coronary heart disease (clinical scenario)
I
Intervention
Long-term anticoagulants (warfarin)
O
Outcome
Embolic strokehard clinical
This article presents a clinical scenario to guide physicians on how to review medical literature regarding anticoagulant use in nonvalvular atrial fibrillation.
Cite This Study
Gordon Guyatt (1994) conducted a review in Atrial fibrillation. Warfarin was evaluated. This educational article presents a clinical scenario to introduce a guide on evaluating the medical literature regarding the use of warfarin for stroke prevention in nonvalvular atrial fibrillation.